C07C 62/22
Polycyclic
Official title: polycyclic
C07C62/22 (Polycyclic) appears on 14 US grants and 1 published applications in this corpus.
Search patents in C07C- Granted patents
- 14
- Published applications
- 1
- Assignees
- 6
- Inventors
- 31
- Latest grant
- 17 Dec 2013
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 1 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 3 | 0 |
| 1999 | 6 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Salt and photoresist composition containing the same17 Dec 2013US 8,609,317 B2Sumitomo Chemical Company, Limited
- Thiophene-containing butonic acid derivatives as matrix metalloprotease inhibitors23 Mar 1999US 5,886,024 ABayer Aktiengesellschaft
- Substituted 4-biarylbutyric acid derivatives as matrix metalloprotease inhibitors23 Mar 1999US 5,886,043 ABayer Aktiengesellschaft
- Substituted cycloalkanecarboxylic acid derivatives as matrix metalloprotease inhibitors23 Feb 1999US 5,874,473 ABayer Aktiengesellschaft
- Substituted 4-biarylbutyric acid derivatives as matrix metalloprotease inhibitors19 Jan 1999US 5,861,427 A
Most cited
By later US patents
- Pharmacologically active 2- and 3-substituted (1',5'-diaryl-3-pyrazolyl)-N-hydroxypropanamides37US 5,051,518 AOrtho Pharmaceutical Corporation · 1991
- Derivatives of substituted 4-biarylbutyric acid as matrix metalloprotease inhibitors28US 5,789,434 ABayer Aktiengesellschaft · 1998
- Bicyclic aromatic compounds, a process for their preparation and their use in cosmetics and human and veterinary medicine15US 4,898,864 AL'oreal · 1990
- Excitatory amino acid receptor antagonists7US 5,717,109 AEli Lilly and Company · 1998
- Thiophenebutanoic acid derivatives as matrix metalloprotease inhibitors7US 5,854,277 ABayer Aktiengesellschaft · 1998